当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析 - 现金流量表

美康生物

(300439)

  

流通市值:27.74亿  总市值:36.43亿
流通股本:2.92亿   总股本:3.84亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金891,094,992.64388,623,587.911,466,908,974.911,303,354,569.38
  收到的税费返还2,362,271.88598,361.015,527,780.563,627,097.13
  收到其他与经营活动有关的现金23,652,94511,927,770.1795,155,169.5988,163,317.53
  经营活动现金流入小计917,110,209.52401,149,719.091,567,591,925.061,395,144,984.04
  购买商品、接受劳务支付的现金508,050,388.68260,140,790.01625,793,258.07713,398,121.97
  支付给职工以及为职工支付的现金191,454,989.06116,454,244.13368,107,760.72288,575,270.61
  支付的各项税费53,541,186.2828,261,825.0395,386,596.8278,669,870.78
  支付其他与经营活动有关的现金101,482,688.9554,117,111.26211,689,398.5169,523,975.73
  经营活动现金流出小计854,529,252.97458,973,970.431,300,977,014.111,250,167,239.09
  经营活动产生的现金流量净额62,580,956.55-57,824,251.34266,614,910.95144,977,744.95
二、投资活动产生的现金流量:
  收回投资收到的现金542,000,000205,000,000973,284,944.25703,000,000
  取得投资收益收到的现金7,510,730.131,169,213.6321,217,025.9719,478,222.7
  处置固定资产、无形资产和其他长期资产收回的现金净额25,000-5,189,322.5101,041.5
  处置子公司及其他营业单位收到的现金净额390,000-363,080.44584,944.25
  收到的其他与投资活动有关的现金---0
  投资活动现金流入小计549,925,730.13206,169,213.631,000,054,373.16723,164,208.45
  购建固定资产、无形资产和其他长期资产支付的现金24,984,160.3518,657,535.89191,407,877.1976,382,180.85
  投资支付的现金697,400,000195,288,0001,067,000,000796,999,900
  取得子公司及其他营业单位支付的现金---0
  投资活动现金流出小计722,384,160.35213,945,535.891,258,407,877.19873,382,080.85
  投资活动产生的现金流量净额-172,458,430.22-7,776,322.26-258,353,504.03-150,217,872.4
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,694,000480,000
  其中:子公司吸收少数股东投资收到的现金--480,000480,000
  取得借款收到的现金60,000,000-34,844,668.060
  收到其他与筹资活动有关的现金--02,214,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计60,000,000-37,538,668.062,694,000
  偿还债务支付的现金20,000,00020,000,00045,000,00030,000,000
  分配股利、利润或偿付利息支付的现金7,571,400.2385,510.4751,992,779.5452,851,878.94
  支付其他与筹资活动有关的现金9,495,734.85-17,258,666.6110,340,066.1
  筹资活动现金流出小计37,067,135.0820,085,510.47114,251,446.1593,191,945.04
  筹资活动产生的现金流量净额22,932,864.92-20,085,510.47-76,712,778.09-90,497,945.04
四、汇率变动对现金及现金等价物的影响-527,761.59-203,657.26-725,233.89-487,295.89
五、现金及现金等价物净增加额-87,472,370.34-85,889,741.33-69,176,605.06-96,225,368.38
  加:期初现金及现金等价物余额657,438,431.29657,438,431.29726,615,036.35726,615,036.35
  期末现金及现金等价物余额569,966,060.95571,548,689.96657,438,431.29630,389,667.97
补充资料:
  净利润61,555,662.61-61,361,976.78-
  资产减值准备5,169,924.16-39,755,116.04-
  固定资产和投资性房地产折旧76,556,755.79-143,604,664.9-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧76,556,755.79-143,604,664.9-
  无形资产摊销7,756,850.59-14,273,559.95-
  长期待摊费用摊销6,980,134.81-13,070,723.67-
  处置固定资产、无形资产和其他长期资产的损失-471.91--1,659,738.98-
  固定资产报废损失7,795.54-302,302.1-
  公允价值变动损失-846,461.54--430,440.4-
  财务费用889,612.4-2,685,101.12-
  投资损失-9,697,793.23--8,724,190.36-
  递延所得税-2,863,445.23--31,091,798.66-
  其中:递延所得税资产减少1,351,827.02--11,815,798.23-
    递延所得税负债增加-4,215,272.25--19,276,000.43-
  存货的减少3,182,745.15-33,853,414.88-
  经营性应收项目的减少-37,146,200.19--64,039,601.58-
  经营性应付项目的增加-55,206,605.21-41,606,677.94-
  其他-135,535.64-7,133,388.68-
  不涉及现金收支的投资和筹资活动金额其他项目--2,942,225.82-
  现金的期末余额569,966,060.95-657,438,431.29-
  减:现金的期初余额657,438,431.29-726,615,036.35-
  现金及现金等价物的净增加额-87,472,370.34--69,176,605.06-
公告日期2026-08-292026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑